Viewing Study NCT00870194


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-03-15 @ 5:27 PM
Study NCT ID: NCT00870194
Status: COMPLETED
Last Update Posted: 2015-04-09
First Post: 2009-03-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: H8O-CR-GWDK
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View